Efficacy and safety of low dose QMF149 (150/80 microgram) compared with MF Twisthaler® in patients with asthma

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-000472-22

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to demonstrate the superiority of QMF149 150/80 microgram o.d. (in the evening) delivered via Concept1 compared with MF 200 microgram o.d. (in the evening) delivered via Twisthaler® in terms of trough FEV1 after 12 weeks of treatment in adults and adolescents.


Critère d'inclusion

  • poorly (ie inadequately)controlled asthma patients